A comparison of alternative assessments of depressive symptom severity

A pilot study

Melanie M. Biggs, Kathy Shores-Wilson, A. John Rush, Thomas J. Carmody, Madhukar H. Trivedi, M. Lynn Crismon, Marcia G. Toprac, Mark Mason

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This study compared the performance of an itemized symptom self-report (Inventory of Depressive Symptomatology - Self-Report; IDS-SR), patient global ratings, and clinician global ratings with an itemized clinician-rated symptom severity measure (Inventory of Depressive Symptomatology - Clinician-Rated; IDS-C) in detecting treatment effects in patients with major depressive disorder (MDD). A total of 28 inpatients (30.8% psychotic) and 34 outpatients (17.9% psychotic) with MDD began treatment that followed the Texas medication algorithm. The clinicians completed the IDS-C and a Physician Global Rating Scale (PhGRS) at each assessment visit, while the patients completed the IDS-SR and a Patient Global Rating Scale (PtGRS). Change scores from the baseline to subsequent weeks were computed for all subjects, utilizing all four measures. The IDS-SR was a significant independent predictor of the response to treatment as compared to the two global ratings. The IDS-SR was as sensitive to change as the IDS-C. While the clinician-rated itemized symptom severity rating scale remains the standard to assess the symptomatic outcome of the treatment of MDD, a self-report of identical symptomatology may be a reasonable alternative for many patients. Copyright (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish (US)
Pages (from-to)55-65
Number of pages11
JournalPsychiatry Research
Volume95
Issue number1
DOIs
StatePublished - Jul 24 2000

Fingerprint

Depression
Major Depressive Disorder
Self Report
Equipment and Supplies
Inpatients
Outpatients
Therapeutics
Physicians

Keywords

  • Global measures
  • Major depressive disorder
  • Self-reports
  • Symptom severity

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

A comparison of alternative assessments of depressive symptom severity : A pilot study. / Biggs, Melanie M.; Shores-Wilson, Kathy; Rush, A. John; Carmody, Thomas J.; Trivedi, Madhukar H.; Crismon, M. Lynn; Toprac, Marcia G.; Mason, Mark.

In: Psychiatry Research, Vol. 95, No. 1, 24.07.2000, p. 55-65.

Research output: Contribution to journalArticle

@article{1b7dff1e416c47c6b0a16a0af73bd3e8,
title = "A comparison of alternative assessments of depressive symptom severity: A pilot study",
abstract = "This study compared the performance of an itemized symptom self-report (Inventory of Depressive Symptomatology - Self-Report; IDS-SR), patient global ratings, and clinician global ratings with an itemized clinician-rated symptom severity measure (Inventory of Depressive Symptomatology - Clinician-Rated; IDS-C) in detecting treatment effects in patients with major depressive disorder (MDD). A total of 28 inpatients (30.8{\%} psychotic) and 34 outpatients (17.9{\%} psychotic) with MDD began treatment that followed the Texas medication algorithm. The clinicians completed the IDS-C and a Physician Global Rating Scale (PhGRS) at each assessment visit, while the patients completed the IDS-SR and a Patient Global Rating Scale (PtGRS). Change scores from the baseline to subsequent weeks were computed for all subjects, utilizing all four measures. The IDS-SR was a significant independent predictor of the response to treatment as compared to the two global ratings. The IDS-SR was as sensitive to change as the IDS-C. While the clinician-rated itemized symptom severity rating scale remains the standard to assess the symptomatic outcome of the treatment of MDD, a self-report of identical symptomatology may be a reasonable alternative for many patients. Copyright (C) 2000 Elsevier Science Ireland Ltd.",
keywords = "Global measures, Major depressive disorder, Self-reports, Symptom severity",
author = "Biggs, {Melanie M.} and Kathy Shores-Wilson and Rush, {A. John} and Carmody, {Thomas J.} and Trivedi, {Madhukar H.} and Crismon, {M. Lynn} and Toprac, {Marcia G.} and Mark Mason",
year = "2000",
month = "7",
day = "24",
doi = "10.1016/S0165-1781(00)00159-1",
language = "English (US)",
volume = "95",
pages = "55--65",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - A comparison of alternative assessments of depressive symptom severity

T2 - A pilot study

AU - Biggs, Melanie M.

AU - Shores-Wilson, Kathy

AU - Rush, A. John

AU - Carmody, Thomas J.

AU - Trivedi, Madhukar H.

AU - Crismon, M. Lynn

AU - Toprac, Marcia G.

AU - Mason, Mark

PY - 2000/7/24

Y1 - 2000/7/24

N2 - This study compared the performance of an itemized symptom self-report (Inventory of Depressive Symptomatology - Self-Report; IDS-SR), patient global ratings, and clinician global ratings with an itemized clinician-rated symptom severity measure (Inventory of Depressive Symptomatology - Clinician-Rated; IDS-C) in detecting treatment effects in patients with major depressive disorder (MDD). A total of 28 inpatients (30.8% psychotic) and 34 outpatients (17.9% psychotic) with MDD began treatment that followed the Texas medication algorithm. The clinicians completed the IDS-C and a Physician Global Rating Scale (PhGRS) at each assessment visit, while the patients completed the IDS-SR and a Patient Global Rating Scale (PtGRS). Change scores from the baseline to subsequent weeks were computed for all subjects, utilizing all four measures. The IDS-SR was a significant independent predictor of the response to treatment as compared to the two global ratings. The IDS-SR was as sensitive to change as the IDS-C. While the clinician-rated itemized symptom severity rating scale remains the standard to assess the symptomatic outcome of the treatment of MDD, a self-report of identical symptomatology may be a reasonable alternative for many patients. Copyright (C) 2000 Elsevier Science Ireland Ltd.

AB - This study compared the performance of an itemized symptom self-report (Inventory of Depressive Symptomatology - Self-Report; IDS-SR), patient global ratings, and clinician global ratings with an itemized clinician-rated symptom severity measure (Inventory of Depressive Symptomatology - Clinician-Rated; IDS-C) in detecting treatment effects in patients with major depressive disorder (MDD). A total of 28 inpatients (30.8% psychotic) and 34 outpatients (17.9% psychotic) with MDD began treatment that followed the Texas medication algorithm. The clinicians completed the IDS-C and a Physician Global Rating Scale (PhGRS) at each assessment visit, while the patients completed the IDS-SR and a Patient Global Rating Scale (PtGRS). Change scores from the baseline to subsequent weeks were computed for all subjects, utilizing all four measures. The IDS-SR was a significant independent predictor of the response to treatment as compared to the two global ratings. The IDS-SR was as sensitive to change as the IDS-C. While the clinician-rated itemized symptom severity rating scale remains the standard to assess the symptomatic outcome of the treatment of MDD, a self-report of identical symptomatology may be a reasonable alternative for many patients. Copyright (C) 2000 Elsevier Science Ireland Ltd.

KW - Global measures

KW - Major depressive disorder

KW - Self-reports

KW - Symptom severity

UR - http://www.scopus.com/inward/record.url?scp=0033949453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033949453&partnerID=8YFLogxK

U2 - 10.1016/S0165-1781(00)00159-1

DO - 10.1016/S0165-1781(00)00159-1

M3 - Article

VL - 95

SP - 55

EP - 65

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1

ER -